SRF Limited (SRF)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 1 August 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹2,622.5 ↓ 13.76% (1Y)

🎯 Key Takeaways

  • SRF Limited is transitioning from a mature chemical producer to a growth-oriented specialty materials company, with strategic investments in high-margin segments like Performance Films & Foil and Technical Textiles driving profitability. The company is in a phase of capital deployment to scale emerging businesses while maintaining strong cash flows from core chemicals.
  • Revenue grew 2% QoQ to ₹3,491 in Q3FY25.
  • ⚠️ Over-reliance on high-growth segments (Performance Films & Foil) that are cyclical and capital-intensive, exposing the company to demand volatility.
Market Cap
₹79,723
P/E Ratio
69.5
Div Yield
0.00%
Promoter
0.0%

📖 The Story

SRF Limited is transitioning from a mature chemical producer to a growth-oriented specialty materials company, with strategic investments in high-margin segments like Performance Films & Foil and Technical Textiles driving profitability. The company is in a phase of capital deployment to scale emerging businesses while maintaining strong cash flows from core chemicals.

📰 What's Happening

In Q1FY27, SRF reported consolidated revenue of ₹5,033 crores, up 32% YoY, with PAT surging 76% to ₹759 crores, reflecting robust segmental growth. Performance Films & Foil revenue rose 42% to ₹2,017 crores, Technical Textiles grew 28% to ₹597 crores, and Chemicals contributed 46% of revenue and 57% of EBIT. The Board approved a ₹250 crore investment for a BOPET thick film line and ongoing capex in Specialty Chemicals to enhance capacity and efficiency. An interim dividend of ₹5 per share was declared, payable by 18 August 2026.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue383,3383,1773,0533,5703,4643,4243,491
Operating Profit10708655585719629571659
OPM %24.7%20.9%19.7%18.5%19.5%17.4%15.7%17.8%
Net Profit6359301253422252201271
EPS₹18.97₹12.12₹10.15₹8.55₹14.24₹8.51₹6.79₹9.15

Revenue and profitability have shown consistent improvement over recent quarters, with OPM expanding from 15.7% in Q2FY25 to 17.8% in Q3FY25, and PAT rising from ₹201 crores in Q2FY25 to ₹271 crores in Q3FY25. The company has demonstrated cyclical strength in Chemicals and growing momentum in Technical Textiles and Performance Films. The latest Q1FY27 results confirm this trajectory, with EBITDA up 61% YoY and PAT margin expanding to 15.1%, supported by favorable product mix and margin recovery in Chemicals.

🔮 Management Outlook & What's Next

Management highlighted the Board's approval of a ₹250 crore capex proposal to establish a BOPET thick film line, aimed at enhancing capacity and efficiency in Specialty Chemicals. This investment underscores the strategic focus on scaling high-growth segments. No formal long-term guidance was provided beyond the capex plan, but management emphasized sustained investment to capture growth in specialty materials and improve operational efficiency.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
Solar Industries India Limited 1.57 L Cr 132.3
Pidilite Industries Limited 1.49 L Cr 75.7
SRF Limited 79,723 69.5
Linde India Limited 62,701 141.9
Gujarat Fluorochemicals Limited 40,793 89.6
Navin Fluorine International Limited 35,894 131.5
Himadri Speciality Chemical Limited 30,071 56.6
Deepak Nitrite Limited 24,911 33.3
Atul Limited 20,904 48.8
Tata Chemicals Limited 19,079 -47.1

⚠️ Risk Factors

1. Over-reliance on high-growth segments (Performance Films & Foil) that are cyclical and capital-intensive, exposing the company to demand volatility. 2. Margin expansion in Chemicals is partly driven by favorable tax write-backs, which may not recur, raising sustainability concerns. 3. Ongoing tax litigation, though reduced, poses residual legal and compliance risk. 4. Capex execution delays or cost overruns in the BOPET project could pressure near-term cash flows and returns.

📋 Recent Filings

🧠 Analyst's Read

SRF is executing a clear strategy to shift toward higher-margin specialty materials, supported by strong quarterly growth and capital allocation toward future capacity. Investors should monitor the progress of the BOPET investment and margin sustainability in Chemicals, while watching for any slowdown in segmental growth or macro headwinds from global chemical demand.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SRF files new disclosures

Track SRF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SRF — Free

Free account · 2 AI queries/day